ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,907,498 | +46.0% | 740,882 | +38.0% | 0.01% | +28.6% |
| Q2 2023 | $13,638,911 | 0.0% | 536,965 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $13,638,911 | -32.5% | 536,965 | +7.8% | 0.01% | -36.4% |
| Q4 2022 | $20,195,676 | -99.3% | 497,921 | +476.6% | 0.01% | +450.0% |
| Q3 2022 | $2,854,199,000 | -26.1% | 86,360 | -21.3% | 0.00% | 0.0% |
| Q2 2022 | $3,863,417,000 | -26.2% | 109,725 | -3.7% | 0.00% | 0.0% |
| Q1 2022 | $5,237,617,000 | -18.6% | 113,886 | +17.3% | 0.00% | 0.0% |
| Q4 2021 | $6,438,325,000 | +4.7% | 97,109 | -1.4% | 0.00% | -33.3% |
| Q3 2021 | $6,148,856,000 | -15.3% | 98,492 | +12.4% | 0.00% | 0.0% |
| Q2 2021 | $7,260,085,000 | +19.7% | 87,661 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $6,064,778,000 | -32.8% | 91,461 | -22.2% | 0.00% | -25.0% |
| Q4 2020 | $9,023,140,000 | +97.5% | 117,596 | +10.8% | 0.00% | +100.0% |
| Q3 2020 | $4,569,484,000 | +0.6% | 106,119 | +0.9% | 0.00% | -33.3% |
| Q2 2020 | $4,542,465,000 | +77.6% | 105,174 | +18.3% | 0.00% | +50.0% |
| Q1 2020 | $2,557,566,000 | -55.2% | 88,897 | -1.3% | 0.00% | -33.3% |
| Q4 2019 | $5,714,663,000 | +122.5% | 90,094 | -1.1% | 0.00% | +50.0% |
| Q3 2019 | $2,568,071,000 | +25.3% | 91,131 | +17.9% | 0.00% | +100.0% |
| Q2 2019 | $2,048,902,000 | +171.2% | 77,317 | +87.8% | 0.00% | 0.0% |
| Q1 2019 | $755,561,000 | +10.1% | 41,175 | -25.5% | 0.00% | 0.0% |
| Q4 2018 | $686,378,000 | -46.8% | 55,264 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $1,289,489,000 | +93.2% | 67,266 | +37.0% | 0.00% | 0.0% |
| Q2 2018 | $667,515,000 | +443.4% | 49,082 | -26.1% | 0.00% | – |
| Q1 2017 | $122,840,000 | +614100.0% | 66,400 | +414.7% | 0.00% | – |
| Q4 2016 | $20,000 | -88.6% | 12,900 | -45.8% | 0.00% | – |
| Q3 2016 | $175,000 | +37.8% | 23,800 | 0.0% | 0.00% | – |
| Q2 2016 | $127,000 | +10.4% | 23,800 | 0.0% | 0.00% | – |
| Q1 2016 | $115,000 | – | 23,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |